Search research articles
Contact Us
Filters
Showing results (41-50 of 100) with videos related to
Page
of 10
Sort By:
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
September 2, 2006
Accuracy of stress Tc-99m tetrofosmin myocardial perfusion tomography for the diagnosis and localization of coronary artery disease in women
Abdou Elhendy, Arend F L Schinkel, Jeroen J Bax, et al.
Radiology
|
December 4, 2002
Long-term prognostic value of dobutamine stress 99mTc-sestamibi SPECT: single-center experience with 8-year follow-up
Arend F L Schinkel, Abdou Elhendy, Ron T Van Domburg, et al.
Seminars in Nuclear Medicine
|
March 7, 2006
Survival and response after peptide receptor radionuclide therapy with [90Y-DOTA0,Tyr3]octreotide in patients with advanced gastroenteropancreatic neuroendocrine tumors
Roelf Valkema, Stanislas Pauwels, Larry K Kvols, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 7, 2005
Risk stratification of patients with angina pectoris by stress 99mTc-tetrofosmin myocardial perfusion imaging
Abdou Elhendy, Arend F L Schinkel, Ron T van Domburg, et al.
The American Journal of Cardiology
|
August 23, 2006
Prognostic value of exercise stress technetium-99m-tetrofosmin myocardial perfusion imaging in patients with normal baseline electrocardiograms
Abdou Elhendy, Arend F L Schinkel, Ron T van Domburg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 18, 2005
Patient-specific dosimetry in predicting renal toxicity with (90)Y-DOTATOC: relevance of kidney volume and dose rate in finding a dose-effect relationship
Raffaella Barone, Françoise Borson-Chazot, Roelf Valkema, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
October 18, 2013
Prediction of 8-year cardiovascular outcomes in patients with systemic arterial hypertension: value of stress (99m)Tc-tetrofosmin myocardial perfusion imaging in a high-risk cohort
Marisa C G Tjong Joe Wai, Machiel J M Ottenhof, Hendrik J Boiten, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 17, 2010
Dynamic and static small-animal SPECT in rats for monitoring renal function after 177Lu-labeled Tyr3-octreotate radionuclide therapy
Marleen Melis, Jan de Swart, Monique de Visser, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 3, 2005
Incremental prognostic value of dobutamine-atropine stress 99mTc-tetrofosmin myocardial perfusion imaging for predicting outcome in diabetic patients with limited exercise capacity
Chiara Pedone, Arend F L Schinkel, Abdou Elhendy, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
June 9, 2012
15-Year outcome after normal exercise ⁹⁹mTc-sestamibi myocardial perfusion imaging: what is the duration of low risk after a normal scan?
Arend F L Schinkel, Henk J Boiten, Jors N van der Sijde, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 100) with videos related to
Sort By:
Page
of 10
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
September 2, 2006
Accuracy of stress Tc-99m tetrofosmin myocardial perfusion tomography for the diagnosis and localization of coronary artery disease in women
Abdou Elhendy, Arend F L Schinkel, Jeroen J Bax, et al.
Radiology
|
December 4, 2002
Long-term prognostic value of dobutamine stress 99mTc-sestamibi SPECT: single-center experience with 8-year follow-up
Arend F L Schinkel, Abdou Elhendy, Ron T Van Domburg, et al.
Seminars in Nuclear Medicine
|
March 7, 2006
Survival and response after peptide receptor radionuclide therapy with [90Y-DOTA0,Tyr3]octreotide in patients with advanced gastroenteropancreatic neuroendocrine tumors
Roelf Valkema, Stanislas Pauwels, Larry K Kvols, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 7, 2005
Risk stratification of patients with angina pectoris by stress 99mTc-tetrofosmin myocardial perfusion imaging
Abdou Elhendy, Arend F L Schinkel, Ron T van Domburg, et al.
The American Journal of Cardiology
|
August 23, 2006
Prognostic value of exercise stress technetium-99m-tetrofosmin myocardial perfusion imaging in patients with normal baseline electrocardiograms
Abdou Elhendy, Arend F L Schinkel, Ron T van Domburg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 18, 2005
Patient-specific dosimetry in predicting renal toxicity with (90)Y-DOTATOC: relevance of kidney volume and dose rate in finding a dose-effect relationship
Raffaella Barone, Françoise Borson-Chazot, Roelf Valkema, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
October 18, 2013
Prediction of 8-year cardiovascular outcomes in patients with systemic arterial hypertension: value of stress (99m)Tc-tetrofosmin myocardial perfusion imaging in a high-risk cohort
Marisa C G Tjong Joe Wai, Machiel J M Ottenhof, Hendrik J Boiten, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 17, 2010
Dynamic and static small-animal SPECT in rats for monitoring renal function after 177Lu-labeled Tyr3-octreotate radionuclide therapy
Marleen Melis, Jan de Swart, Monique de Visser, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 3, 2005
Incremental prognostic value of dobutamine-atropine stress 99mTc-tetrofosmin myocardial perfusion imaging for predicting outcome in diabetic patients with limited exercise capacity
Chiara Pedone, Arend F L Schinkel, Abdou Elhendy, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
June 9, 2012
15-Year outcome after normal exercise ⁹⁹mTc-sestamibi myocardial perfusion imaging: what is the duration of low risk after a normal scan?
Arend F L Schinkel, Henk J Boiten, Jors N van der Sijde, et al.
Page
of 10